Hyperviscosity Syndrome Symptoms and Management

Classic Symptom Triad

The European Society of Cardiology notes that hyperviscosity symptoms include vision changes, such as blurred vision, visual impairment, and retinal changes, which may progress to central retinal vein occlusion, as well as neurologic abnormalities, including headache, dizziness, faintness, confusion, altered mental status, seizures, cranial nerve palsies, and limb weakness, and bleeding manifestations, such as spontaneous epistaxis, mucosal bleeding, dental bleeding, easy bruising, menorrhagia, and hemoptysis 1, 2

The European Society of Cardiology classifies hyperviscosity symptoms by functional impact, with moderate symptoms interfering with some daily activities and severe symptoms interfering with most daily activities 1

In patients with cyanotic heart disease and erythrocytosis, hyperviscosity symptoms are unlikely when hematocrit remains below 65% in iron-replete patients, and the American College of Cardiology emphasizes that symptoms mimic those of iron deficiency, creating diagnostic confusion 1, 3
The American College of Cardiology recommends that patients with hyperviscosity symptoms due to cyanotic heart disease and erythrocytosis be evaluated for iron deficiency, as it can produce identical symptoms to hyperviscosity but requires opposite management 3
In Waldenström macroglobulinemia, patients typically become symptomatic when serum viscosity exceeds 4.0 centipoise, though some develop retinal changes at lower levels, and symptoms include visual disturbances, neurologic symptoms, bleeding diathesis, and cardiovascular symptoms 2, 5

The American Heart Association emphasizes that dehydration must be excluded first, as it exacerbates symptoms and mimics true hyperviscosity, and rehydration with oral fluids or intravenous normal saline serves as first-line therapy before considering more aggressive interventions 3
The American College of Cardiology notes that the severity and frequency of hyperviscosity symptoms do not correlate reliably with measured hematocrit or viscosity levels, and symptom assessment cannot substitute for objective measurements, and vice versa 3

Therapeutic intervention is indicated when hemoglobin exceeds 20 g/dL and hematocrit exceeds 65%, hyperviscosity symptoms are present and interfere with function, adequate hydration has been confirmed, and iron deficiency has been excluded 1, 3, 4